UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...

A silent killer that is the second leading cause of death among American men, prostate cancer is a disease that has recently come to the forefront of medical research. Studies and new reviews are ...

Stage 2 prostate adenocarcinoma is localized, with a nearly 100%, five-year relative survival rate. Diagnosis uses the TNM system, PSA levels and Gleason score to determine cancer stage and risk.

Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting patient impact. At the 2026 ASCO GU meeting, experts gathered to share the ...

Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing ...

What happens if PSA levels start rising after surgery or radiation for prostate cancer? Up to a third of men treated for the disease will eventually confront this problem. If there's no accompanying ...

The beloved 'Today' anchor was first diagnosed after bloodwork at a routine checkup showed elevated prostate specific antigen (PSA) levels. Since 1979, Al Roker says he's averaged some sort of surgery ...

Prostate cancer screening compares favorably to screening for breast cancer in identifying significant cancers, reducing ...

What Is Akeega, and Why Does It Matter? Akeega is a dual-action tablet combining two medicines — niraparib and abiraterone acetate — that has been approved by the FDA in combination with prednisone (a ...

The analysis – reported at the European Association of Urology (EAU) annual congress in London, UK – shows that it is "no longer rational to reject prostate cancer screening on one hand while ...